Kirill Neumann

Kirill Neumann

Auto-generated profile, based on publicly available information

Kirill Neumann

Pulmonary Department, Akershus University Hospital, Lørenskog, Norway

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2024 in Acta Oncologica
Verified
Journal Article
Open access
PDF file
AGAnja Gouliaev
Anja Gouliaev
JBJanna Berg
Janna Berg
RBRana Bibi
Rana Bibi
AAArman Arshad
Arman Arshad
HLHåkon Olav Leira
Håkon Olav Leira
TRTorben R. Rasmussen
Torben R. Rasmussen
Background and purpose: Multi-disciplinary Team (MDT) meetings are widely regarded as the ‘gold standard’ of lung cancer care. MDTs improve adherence to clinical guidelines for lung cancer patients. In this study, we describe and compare lung cancer MDTs in Denmark and Norway by combining national surveys and the MDT-Metric for the Observation of Decision-making (MDT-MODe) instrument. Materials and method: Identical surveys were sent out to all lung cancer MDT centers in Denmark and Norway by the Danish Lung Cancer Group and the Norwegian Lung Cancer Group. Six MDT centers, three in Denmark and three in Norway, were observed using the MDT-MODe instrument. Results and interpretation: We found similar organization of MDT meetings in both countries, with the main difference being more local MDT meetings in Norway. All lung cancer MDTs were chaired by respiratory physicians and attended by a radiologist. Other members included oncologists, pathologists, thoracic surgeons, specialist nurses, nuclear medicine specialists and junior doctors. Overall, members reported that they had sufficient time for preparation and attending MDT meetings. With the MDT-MODe instrument it was found that the MDT chairs, surgeons, oncologists, radiologists all contributed positively to case discussion. Comorbidities were included in the discussion of most patients while the patient’s view and psychosocial issues were less often discussed. A treatment decision was reached in 79.7% of cases discussed. In conclusion, we found similar settings and overall good quality concerning lung cancer MDT meetings in Denmark and Norway.

4 June 2025 in Acta Oncologica
Verified
Journal Article
Open access
PDF file
GKGhida Khalife
Ghida Khalife
JWJuho Waris
Juho Waris
UBUffe Bødtger
Uffe Bødtger
JIJohan Isaksson
Johan Isaksson
KNKirill Neumann
Kirill Neumann
PTPaulus Torkki
Paulus Torkki
Background: Lung cancer (LC) is the leading cause of cancer-related deaths worldwide. Despite societal, economic and genetic similarities, 5-year age-standardized relative survival rate is lower in Finland compared to the other Nordic countries. Previous studies have identified discrepancies in LC guidelines, but research on actual care practices remains limited. We aim to address this knowledge gap by conducting a comprehensive examination of the current care practices for LC patients in the Nordic countries. Methods: We employed a non-interventional, prospective study design. We conducted an expert workshop involving LC specialists from Finland to formulate relevant questions for a structured survey. This survey was distributed to healthcare professionals (HCPs) across Nordic hospitals and primary care units. The survey results were then analyzed, and a follow-up Nordic LC expert workshop was held to identify the most relevant factors potentially influencing LC survival outcomes. Results: Four key differences in care practices between Finland and other Nordic countries were identified: (1) resources available in primary care units, (2) waiting times in primary care, (3) availability of novel treatments and (4) tracking of LC survival and mortality outcomes by the hospital. Finland has the lowest access to computed tomography (CT) from primary care, longest waiting times in primary care, and lacks a national outcome tracking system. Some medical doctors in Finland and Iceland highlighted observed limitations in specific cases involving access to neoadjuvant immunotherapy and chemotherapy. Interpretation: Several factors unrelated to specialized LC care are likely contributing to poorer 5-year survival rates for LC in Finland. These findings may be applicable to other healthcare systems as well.

1 August 2025 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
NMNina Maksimovic
Nina Maksimovic
KNKirill Neumann
Kirill Neumann
HAHenrik Aamodt
Henrik Aamodt
RERune Eggum
Rune Eggum
FRFrode Reier-Nilsen
Frode Reier-Nilsen
KSKnut Stavem
Knut Stavem
Background: When starting with new surgical procedures, a gradual improvement in skills and results is expected. Pulmonary resection for early-stage non-small cell lung cancer (NSCLC) has advanced with technology, making robot-assisted thoracic surgery (RATS) an increasingly preferred method. At Akershus University Hospital (Ahus), exploring the learning curve associated with RATS offered valuable insights for optimizing surgical efficiency and improving patient outcomes. This study analyzes key operational variables and outcomes to highlight the skill acquisition process at a leading Norwegian healthcare center, aiming to describe the learning curve involved in transitioning from video-assisted thoracic surgery (VATS) to RATS for lung cancer lobectomies. Methods: This study was a retrospective analysis of the first 200 consecutive pulmonary lobectomies and bi-lobectomies with RATS in Norwegian University Hospital. We used cumulative sum (CUSUM) and risk-adjusted CUSUM (RA-CUSUM) analyses to evaluate operative times and perioperative complications. Results: The 200 patients had a median age of 70 (25th–75th percentile, 62–75) years; 109 (55%) were female, 159 (80%) had preoperative stage 0–IB, and 34 (17%) stage IIA–IIB. Of the procedures, 196 were lobectomies and 4 bi-lobectomies. Median operating time was 160 (25th–75th percentile, 120–195) minutes. Complications (Clavien-Dindo grade ≥2) were observed in 25.5% of cases. The conversion rate to thoracotomy was 1.5% and re-operation rate 3.0%. CUSUM analysis indicated a bi-phasic learning curve for operative times, with ongoing improvements observed after the 117th procedure. The RA-CUSUM analysis showed a steady decline in perioperative complications after the 94th procedure. Conclusions: The findings suggest that the transition from VATS to RATS as a standard surgical approach for pulmonary lobectomies was associated with an acceptable development of proficiency, procedure duration, and complication rates over time. Hence, implementation of the new RATS program was feasible and effective.

3 February 2026 in Acta Oncologica
Verified
Journal Article
Open access
AMAlbin Mahovkic
Albin Mahovkic
KNKirill Neumann
Kirill Neumann
TSTrond-Eirik Strand
Trond-Eirik Strand
OROluf Røe
Oluf Røe
HAHaseem Ashraf
Haseem Ashraf
Background and purpose: Implementation of low-dose computed tomography (LDCT) screening for lung cancer is recommended. The Norwegian Lung Cancer Screening pilot (TIDL) has been conducted to explore recruitment strategy, detection rate and the value of a radiology-led screening program. This publication presents baseline results from the screened participants. Patient/material and methods: All 125,095 individuals aged 60–79 years in Akershus county, Norway were invited to participate. Ever-smokers completed a risk questionnaire based on the PLCOm2012NoRace model: those with ≥35 pack-years or a ≥2.6% 6-year lung cancer risk were eligible for inclusion. Of 2,499 eligible participants, 1,006 underwent baseline LDCT between August 2022 and May 2023, and up to two more rounds later. Nodules were categorized by Lung-RADS v2022. Follow-up and staging were managed by thoracic radiologists; High-suspicion cases were referred to pulmonologists.Results: At baseline, lung cancer was diagnosed in 23 participants (2.3%), whereof 19 (83%) in stage I and 2 (9%) in stage II. Most underwent curative treatment, primarily robot-assisted surgery. Only 2.9% of the screened individuals were referred for further diagnostic evaluation. The false positive rate was 0.6% after pulmonologist referral and 1.7% after radiological staging. A total of 13.8% required 3- or 6-month imaging follow-up. Complication rates from diagnostic procedures were low.Interpretation: LDCT screening using combined risk-based eligibility and a radiology-led model is feasible and effective in the Norwegian context. The high detection rate and low clinical burden support its potential for national implementation. These findings may guide the development of future lung cancer screening programs in the Nordic countries and beyond.

8 January 2025 in Acta Oncologica
Verified
Journal Article
Open access
PDF file
KNKirill Neumann
Kirill Neumann
JBJanna Berg
Janna Berg
HAHaseem Ashraf
Haseem Ashraf
JIJohan Isaksson
Johan Isaksson
AKAija Knuuttila
Aija Knuuttila
TRTorben R. Rasmussen
Torben R. Rasmussen
Background and purpose: There is limited data on the real-world management of incidental pulmonary nodules (IPN). In this article, we review current practices and adherence to international guidelines in the Nordic countries. Materials and methods: This non-interventional, observational survey study based on an online survey consisting of 13 questions. In total, 32 hospitals responded to the survey, with 11 from Denmark, 10 from Sweden, 7 from Norway, and 4 from Finland, resulting in an overall response rate of 86% (32/37). These institutions reported following a median of 20 new lung nodules monthly (5–400 IPN cases per month). Results: In Denmark and Sweden, 100% of respondents indicated the presence of national guidelines. In Norway, this rate was 86%, and in Finland 80%. Among the primary guidelines followed, 70% of respondents reported using national guidelines, 20% used international guidelines, and only 10% reported relying on local/institutional guidelines as their first choice. Most sites used a combination of international and national guidelines (75%, 24/32). Available international guidelines were equally represented, with 35% using the Fleischner Criteria, 30% using British Thoracic Society guidelines, and 35% using others (e.g. European Society for Medical Oncology, National Comprehensive Cancer Network). There was variation in which department held primary responsibility for IPN follow-up. The article also demonstrated differences in suggested follow-up cases from the survey. Interpretation: The study reveals strong adherence to guidelines among Nordic hospitals, with a notable preference for hybrid approaches that combine different guidelines. We need continued efforts to harmonize and update guidelines.

6 January 2026 in Journal of Cancer Policy
Verified
Journal Article
Open access
MBMorten Borg
Morten Borg
KNKirill Neumann
Kirill Neumann
JFJannie Christina Frølund
Jannie Christina Frølund
GKGhida Khalife
Ghida Khalife
ZSZaigham Saghir
Zaigham Saghir
TRTorben Riis Rasmussen
Torben Riis Rasmussen
Lung cancer is the leading cause of cancer-related death worldwide, with early detection critical for curative treatment. Low-dose computed tomography (LDCT) can detect lung cancer at earlier stages, but its implementation in the Nordic countries remains limited. This study surveys invasive respiratory physicians in Sweden, Finland, Norway, and Denmark to explore their views on LDCT screening. A web-based survey was conducted among invasive respiratory physicians in Denmark, Norway, Sweden, and Finland to assess opinions on lung cancer screening. Responses were analysed using descriptive statistics and the Kruskal-Wallis test. A total of 125 respondents from 54 Nordic hospitals completed the survey. The majority reported no prior experience with LDCT screening. Most physicians were familiar with LDCT and recognized its potential to improve early detection, though opinions on national implementation were mixed. Key barriers identified included financial constraints, lack of trained personnel, and limited access to CT scanners. Significant differences were observed by country, hospital type, and years of clinical experience (p < 0.05). Nordic respiratory physicians acknowledge the benefits of LDCT screening for early lung cancer detection but highlight substantial implementation challenges, particularly related to resources and personnel. Addressing these barriers, standardizing protocols, and exploring supportive measures such as risk-scores and AI-assisted imaging will be essential for successful adoption of national screening programs across the Nordic region.